April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The correlation between survival and AJCC staging and genetic status in uveal melanoma patients
Author Affiliations & Notes
  • Jens F Kiilgaard
    Dept of Ophthalmology, Rigshospitalet, Copenhagen, Denmark
    Dept of Ophthalmology, Glostrup Hospital, Glostrup, Denmark
  • Mette Bagger
    Dept of Ophthalmology, Rigshospitalet, Copenhagen, Denmark
    Dept of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
  • Morten T Andersen
    Dept of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
  • Steffen Heegaard
    inst of Eye Patology, Copenhagen University, Copenhagen, Denmark
    Dept of Ophthalmology, Glostrup Hospital, Glostrup, Denmark
  • Mette K Andersen
    Dept of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5080. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jens F Kiilgaard, Mette Bagger, Morten T Andersen, Steffen Heegaard, Mette K Andersen; The correlation between survival and AJCC staging and genetic status in uveal melanoma patients. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5080.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate the predictive value of genetic status and AJCC Staging in patients with uveal melanoma.

 
Methods
 

Patient charts for patients treated during 2009 and 2012 were reviewed. Information on survival, AJCC stage and Chromosomal status were collected.

 
Results
 

A total number of 151 patients with either Ciliary or choroidal melanoma were treated at Copenhagen University Hospital between 1 jan 2009 and 31 dec 2012. in 12 cases no genetic information were found. 27.5% of the patients had a normal chromosome status. Normal chromosomal status was found in 9 of 26 stage 1, 28 of 91 stage 2, 4 of 32 stage 3 and 0 of 2 stage 4 patients. A overall survival rate of 63 % after 4 years were observed. Only 1 melanoma related death was observed in the group with normal chromosomal status. There was a direct correlation between AJCC staging and death and number of abnormal chromosomes and death. A combination of AJCC staging and chromosomal status gave the best prediction of melanoma related death.

 
Conclusions
 

AJCC staging and chromosomal status are good predictors of survival. For prediction of melanoma related death a combination of AJCC staging and chromosomal status gave the best results

  
Keywords: 589 melanoma • 744 tumors • 745 uvea  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×